Showing results (11-20 of 3,631) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|January 3, 2015
Demographic and practice characteristics of pathologists who enjoy breast tissue interpretationNatalia V Oster, Berta M Geller, Patricia A Carney, et al.Breast (Edinburgh, Scotland)|January 6, 2015
Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: a reviewJacques Bernier, Philip PoortmansBreast (Edinburgh, Scotland)|December 3, 2014
Feasibility of tailored follow-up for patients with early breast cancerMarjan van Hezewijk, Dennis J F Smit, Esther Bastiaannet, et al.Breast (Edinburgh, Scotland)|July 8, 2014
Genomic profiling of inflammatory breast cancer: a reviewFrançois Bertucci, Pascal Finetti, Peter Vermeulen, et al.Breast (Edinburgh, Scotland)|September 2, 2014
Surgeon bias in sentinel lymph node dissection: Do tumor characteristics influence decision making?Kristin A Robinson, Barbara A Pockaj, Nabil Wasif, et al.Breast (Edinburgh, Scotland)|June 13, 2013
Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancerMasahiro Ohara, Hideo Shigematsu, Yasuhiro Tsutani, et al.Breast (Edinburgh, Scotland)|June 8, 2012
Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancerD L Nielsen, H Nørgaard, L W Vestermark, et al.Breast (Edinburgh, Scotland)|March 26, 2013
Patients' understanding of medical terminology used in the breast clinicR L O'Connell, S K Hartridge-Lambert, N Din, et al.Breast (Edinburgh, Scotland)|March 26, 2013
Surgical margins and risk of locoregional recurrence in invasive breast cancer: an analysis of 10-year data from the Breast Cancer Treatment Quality Assurance ProjectEirene C Behm, Kerri R Beckmann, Jane E Dahlstrom, et al.Breast (Edinburgh, Scotland)|January 7, 2016
Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumorsRikiya Nakamura, Naohito Yamamoto, Nobumitsu Shiina, et al.Pageof 364